{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:51:44Z","timestamp":1791348704062,"version":"4.3.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.jacl.2010.11.004","type":"journal-article","created":{"date-parts":[[2010,11,20]],"date-time":"2010-11-20T09:45:08Z","timestamp":1290246308000},"page":"37-44","source":"Crossref","is-referenced-by-count":59,"title":["Etiology and risk of lactescent plasma and severe hypertriglyceridemia"],"prefix":"10.1016","volume":"5","author":[{"given":"Karine","family":"Tremblay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"M\u00e9thot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2010.11.004_bib1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMcp070061","article-title":"Clinical practice. Hypertriglyceridemia","volume":"357","author":"Brunzell","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2010.11.004_bib2","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1093\/hmg\/ddp361","article-title":"A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia","volume":"18","author":"Hegele","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacl.2010.11.004_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11010-008-0005-1","article-title":"Hypertriglyceridemia: phenomics and genomics","volume":"326","author":"Hegele","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacl.2010.11.004_bib4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.jacl.2010.11.004_bib5","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/jcp.2008.055756","article-title":"Investigation and management of hypertriglyceridaemia","volume":"61","author":"Ferns","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jacl.2010.11.004_bib6","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ajg.2009.27","article-title":"Hypertriglyceridemic pancreatitis: presentation and management","volume":"104","author":"Tsuang","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacl.2010.11.004_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI103069","article-title":"The relation of neutral fat to lactescence of serum","volume":"34","author":"Albrink","year":"1955","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2010.11.004_bib8","first-page":"383","article-title":"Significance of lactescence in blood serum","volume":"1","author":"Van Eck","year":"1952","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2010.11.004_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosissup.2010.03.004","article-title":"Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency","volume":"11","author":"Gaudet","year":"2010","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.jacl.2010.11.004_bib10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/FPC.0b013e328340095e","article-title":"Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics","volume":"20","author":"Brisson","year":"2010","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.jacl.2010.11.004_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1056\/NEJM196701122760206","article-title":"Fat transport in lipoproteins\u2014an integrated approach to mechanisms and disorders","volume":"276","author":"Fredrickson","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2010.11.004_bib12","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1172\/JCI107334","article-title":"Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man","volume":"52","author":"Brunzell","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2010.11.004_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/mgme.2000.3144","article-title":"A sequence variation in the mitochondrial glycerol-3-phosphate dehydrogenase gene is associated with increased plasma glycerol and free fatty acid concentrations among French Canadians","volume":"72","author":"St-Pierre","year":"2001","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jacl.2010.11.004_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9149(98)00328-2","article-title":"Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians","volume":"82","author":"Gaudet","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2010.11.004_bib15","series-title":"Lipoproteins in Health and Disease","first-page":"745","article-title":"Erroneous laboratory values due to severe hypertriglyceridemia","author":"Bhatnagar","year":"1999"},{"key":"10.1016\/j.jacl.2010.11.004_bib16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/clinchem\/25.3.494a","article-title":"Interference by lactescence in glycohemoglobin analysis","volume":"25","author":"Dix","year":"1979","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2010.11.004_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/CIRCGENETICS.109.908905","article-title":"Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects","volume":"3","author":"Franssen","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacl.2010.11.004_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.atherosclerosis.2009.07.039","article-title":"Prevalence and function of anti-lipoprotein lipase auto-antibodies in type V hyperchylomicronemia","volume":"208","author":"Moret","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2010.11.004_bib19","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1210\/jc.2005-0205","article-title":"Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia","volume":"90","author":"Pruneta-Deloche","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2010.11.004_bib20","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2789","article-title":"Familial lipoprotein lipase deficiency, apo CII deficiency and hepatic lipase deficiency","author":"Brunzell","year":"2001"},{"key":"10.1016\/j.jacl.2010.11.004_bib21","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI24471","article-title":"Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment","volume":"115","author":"Mar\u00e7ais","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2010.11.004_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-2275(20)41328-8","article-title":"Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia","volume":"34","author":"Demant","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2010.11.004_bib23","first-page":"266","article-title":"Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotype","volume":"61","author":"Berger","year":"1982","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jacl.2010.11.004_bib24","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/302903","article-title":"Glycerol as a correlate of impaired glucose tolerance: dissection of a complex system by use of a simple genetic trait","volume":"66","author":"Gaudet","year":"2000","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287410004320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287410004320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T21:52:30Z","timestamp":1636840350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287410004320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1933287410004320"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2010.11.004","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}